IP Library Assignment 059156/0055
Patent Assignment
Reel/Frame 059156/0055

Assignment of Assignor's Interest

Recorded: 2022-03-03 Pages: 7
Assignors
DUBE, SUSHANT OMPRAKASH
Executed: 2022-02-15
SAOJI, SUPRIT DILIP
Executed: 2022-02-15
CHATKI, PANKAJ KISAN
Executed: 2022-02-15
PILLAI, SUMITRA ASHOKKUMAR
Executed: 2022-02-15
KORE, GIRISH G.
Executed: 2022-02-15
Assignee
SLAYBACK PHARMA LLC
301 CARNEGIE CENTER, SUITE 303, PRINCETON, NEW JERSEY, 08540
Covered Property (1)
Pharmaceutical Compositions of Cabozantinib
Application: 17/673,583 →
Publication: US 2022/0265633
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Sep 27, 2023
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065045/0560 →
Release of Security Interest Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
Confirmatory Grant of Security Interest in United States Patents Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →
Assignment of Assignor's Interest Apr 18, 2025
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 070877/0696 →